| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2023/10/05 | 21 : 00 | GlobeNewswire Inc. | Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023 | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/10/02 | 20 : 33 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/26 | 13 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 24 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 23 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 17 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/22 | 02 : 12 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 59 | Edgar (US Regulatory) | Form SC 13E3/A - Going private transaction by certain issuers: [Amend] | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 42 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 39 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 37 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 32 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 30 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 24 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 21 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 18 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 16 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 14 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 12 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |
| 2023/09/21 | 23 : 10 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:PRTK | Paratek Pharmaceuticals Inc |